Company filings profile · CIK 0001453687
Cartesian Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Cartesian Therapeutics, Inc. (RNAC): 5 filings in the last 90 days vs 13 in the prior 90 (filing-velocity cooling ↓ · 0.38×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 30, 2026. Source-linked, daily-refreshed.
Material 8-K events — Cartesian Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 29, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 17, 2026 | Item 5.07 | ↗ |
| Jun 9, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 26, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 30, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Departure/Election of Directors or Officers | ↗ |
| Mar 9, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jan 9, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch Cartesian Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 29, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | SCHEDULE 13G | ↗ | |
| Aug 6, 2026 | 10-Q | 10-Q | ↗ |
| Aug 6, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 22, 2026 | SCHEDULE 13G/A | ↗ | |
| Jun 17, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 9, 2026 | 144 | ↗ | |
| Jun 9, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 2, 2026 | 144 | ↗ | |
| May 26, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Apr 30, 2026 | S-8 | S-8 | ↗ |
| Apr 30, 2026 | 10-Q | 10-Q | ↗ |
| Apr 30, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 28, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 28, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 6, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Apr 6, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Apr 2, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 30, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| Mar 13, 2026 | 4 | FORM 4 | ↗ |
| Mar 13, 2026 | SCHEDULE 13G | ↗ | |
| Mar 9, 2026 | 10-K | 10-K | ↗ |
| Mar 9, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Feb 5, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 13, 2026 | 144 | ↗ | |
| Jan 9, 2026 | 144 | ↗ | |
| Jan 9, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jan 8, 2026 | 4 | FORM 4 | ↗ |
| Jan 8, 2026 | 4 | FORM 4 | ↗ |
| Jan 8, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |
| Jan 6, 2026 | 4 | FORM 4 | ↗ |